Intravenous Hydration Therapy Market To Reach $5.66 Billion By 2033

Intravenous Hydration Therapy Market Growth & Trends

The global intravenous hydration therapy market size is expected to reach USD 5.66 billion by 2033, according to a new report by Grand View Research, Inc. Furthermore, the market is expected to register a CAGR of 9.0% from 2025 to 2033. The increasing adoption and awareness regarding procedures that aid in providing fast action and the growing adoption of beautification procedures are expected to provide growth opportunities to the market. IV hydration therapy is a medical treatment that involves administering electrolytes, vitamins, and fluids directly into the bloodstream through an intravenous (IV) catheter.

The therapy is intended to give effective and rapid nutrient replenishment and rehydration to anyone suffering from vitamin deficiencies, dehydration, or other medical problems. IV hydration therapy is one of the most efficient methods of delivering critical fluids to the body. The therapy has been widely adopted during the pandemic and during the severe influenza season. Severe influenza seasons and adverse weather events have contributed to IV fluid shortages in the U.S. in recent years. Due to these shortages, healthcare facilities and professionals have been forced to employ alternative approaches or postpone patient treatments.

Moreover, there are several investments in the field of hydration therapy in order to increase production capacity and make the technique better available to the target audience. For instance, in December 2022, REVIV launched a new and exclusive IV therapy infusion clinic in Harrods that offers IV hydration therapy. Clinics, medical spas, and various other facilities are actively investing in adopting the procedure in their healthcare settings, owing to an increasing demand among the target population.

Some of the benefits offered by IV hydration therapy include the treatment of various conditions such as dehydration occurring due to alcohol consumption, illness, exercise, fatigue, migraine, and other immune system deficiencies. This factor is further expected to propel the industry’s growth. Key players operating in the market are focusing on product launches that may help enhance IV hydration therapy adoption.

For instance, in July 2022, Sameday Health announced the launch of the Inner Beauty IV drip therapy. The drip contains vitamin B complex vitamins and Vitamin C that would help in reducing wrinkles, fortifying the nails and hair, and hydrating the skin. The therapy has been made available at Sameday Health clinics across the globe.

 Request a free sample copy or view report summary: Intravenous Hydration Therapy Market Report

Intravenous Hydration Therapy Market Report Highlights

• The energy boosters segment held the largest market share of 25.29% in 2024. The segment's dominance is due to the rising popularity of these therapies for providing quick and effective energy solutions.

• The medicated segment held the largest revenue share of 67.4% in the IV hydration therapy market in 2024. This dominance is due to the increasing demand for medications administered through the IV route, along with key players focusing on developing customizable medicated IV hydration therapy solutions.

• Physical providers segment held the largest market share in the IV hydration therapy market, driven by the widespread presence of wellness clinics, hospitals, and specialized IV therapy centers offering treatments for dehydration, fatigue, skin health, and immunity support.

• Hospitals & clinics held the dominant market share in 2024. The segment growth can be attributed to the rising need for hospitalization due to an increase in the number of people suffering from chronic disorders.

• North America intravenous (IV) hydration therapy market dominated the global market with a share of 46.8% in 2024 and is anticipated to maintain its dominance over the forecast period.

Intravenous Hydration Therapy Market Segmentation

Grand View Research has segmented the global intravenous hydration therapy market on the basis of service, component, provider type, end use and regions:

Intravenous Hydration Therapy Service Outlook (Revenue, USD Million, 2021 - 2033)

• Immune Boosters

• Energy Boosters

• Hydration

• Beauty/ Aesthetics

• Detoxification

• Longevity/ Antiaging

• Performance/ Athletics

• Migraine & Pain Relief

• Stress/Sleep/Mood Support

• Flu/Stomach

• Others

Intravenous Hydration Therapy Component Outlook (Revenue, USD Million, 2021 - 2033)

• Medicated

• Non-medicated

Intravenous Hydration Therapy Provider Type Outlook (Revenue, USD Million, 2021 - 2033)

• Mobile Providers

• Physical Providers

Intravenous Hydration Therapy End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Hospitals & Clinics

• Wellness Centers and Spas

• Home Healthcare

• Others

Intravenous Hydration Therapy Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Intravenous Hydration Therapy Market

• Baxter

• B. Braun SE

• Otsuka Pharmaceutical Co., Ltd.

• Grifols, S.A.

• Vifor Pharma Management Ltd.

• JW Life Science Corporation

• Amanta Healthcare

• NexGen Health

• Core IV Therapy, LLC

• Cryojuvenate UK Ltd.

• Drip Hydration

• REVIV